Contemporary management of advanced prostate cancer: an evolving landscape
| Autor: | Abhinav, Khanna, Luke P, O'Connor, Prithvi B, Murthy, Darren J, Bryk, Michele, Fascelli, Kyle, Ericson, Nitin K, Yerram, Samuel C, Haywood, Robert, Abouassaly |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Diagnostic Imaging
Male Clinical Trials as Topic Therapies Investigational Disease Management Prostatic Neoplasms Docetaxel Adenocarcinoma Combined Modality Therapy Prostatic Neoplasms Castration-Resistant Benzamides Nitriles Phenylthiohydantoin Humans Multicenter Studies as Topic Androstenes Radiotherapy Adjuvant Taxoids Precision Medicine Radium |
| Zdroj: | Clinical advances in hematologyoncology : HO. 19(2) |
| ISSN: | 1543-0790 |
| Popis: | Recent population-based studies suggest that the incidence of advanced and metastatic prostate cancer may be increasing. Concurrently with this apparent stage migration toward advanced disease, several major developments have occurred in the treatment paradigm for men with advanced prostate cancer. These include the US Food and Drug Administration approval of 8 novel agents over the last decade. In addition to novel pharmaceuticals, rapidly evolving diagnostic tools have emerged. This review provides a primer for clinicians who treat men with advanced prostate cancer, including medical oncologists, radiation oncologists, and urologists. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|